Table S4. Significantly mutated gene test by MuSiC2. TP53 and FANCC were shown to have the highest number of mutations per Million base pair (Muts pMbp). (XLSX 12 kb
Figure S3. DNA copy number alterations in the IBC cohort. The genes with DNA copy number alterations...
Supplementary Tables. Table S1 lists the number of SNV and indel mutations found in each individual ...
Figure S2. Comparison of biological pathway between IBC and non-IBC in four subgroups. (a) The perce...
Table S3. Driver gene analysis by MutSig. The two genes with q value <â10â3 (TP53 and FANCC, hig...
Table S2. Pathogenic and likely pathogenic mutations identified in the studied cohort. Annotations a...
Table S3. Correlation between clinical risk factors of hereditary breast cancer and having pathogeni...
List of all mutations. This file shows all mutations passing thresholds as explained in “Methods”. T...
Deleterious BRCA1/2 germline mutations in Pakistani patients with TNBC. (DOCX 24Â kb
Figure S1. Comparison of somatic mutation frequency between IBC and non-IBC in four subgroups. (a) T...
Taqman assays used for CNV assessment at 7 gene loci. Table S3. Cancer-predisposing genes disrupted ...
Figure S2. Mean sequencing read depth for (A.) the 46 solid tumor cohort. (B.) isolated mononuclear ...
BRCA1 gene expression, measured by RT-PCR, for BRCA1-methylated, mutated and non-mutated/non-methyla...
Figure S4. MFS curves stratified by PIK3CA mutation in three subgroups of IBC patients. (a) Kaplan-M...
Clinical description of cancer patients. Table S2 Statistics of whole-genome sequencing results. Tab...
Specific mutations within affected pathways. This file shows all pathways with KEGG IDs, and mutatio...
Figure S3. DNA copy number alterations in the IBC cohort. The genes with DNA copy number alterations...
Supplementary Tables. Table S1 lists the number of SNV and indel mutations found in each individual ...
Figure S2. Comparison of biological pathway between IBC and non-IBC in four subgroups. (a) The perce...
Table S3. Driver gene analysis by MutSig. The two genes with q value <â10â3 (TP53 and FANCC, hig...
Table S2. Pathogenic and likely pathogenic mutations identified in the studied cohort. Annotations a...
Table S3. Correlation between clinical risk factors of hereditary breast cancer and having pathogeni...
List of all mutations. This file shows all mutations passing thresholds as explained in “Methods”. T...
Deleterious BRCA1/2 germline mutations in Pakistani patients with TNBC. (DOCX 24Â kb
Figure S1. Comparison of somatic mutation frequency between IBC and non-IBC in four subgroups. (a) T...
Taqman assays used for CNV assessment at 7 gene loci. Table S3. Cancer-predisposing genes disrupted ...
Figure S2. Mean sequencing read depth for (A.) the 46 solid tumor cohort. (B.) isolated mononuclear ...
BRCA1 gene expression, measured by RT-PCR, for BRCA1-methylated, mutated and non-mutated/non-methyla...
Figure S4. MFS curves stratified by PIK3CA mutation in three subgroups of IBC patients. (a) Kaplan-M...
Clinical description of cancer patients. Table S2 Statistics of whole-genome sequencing results. Tab...
Specific mutations within affected pathways. This file shows all pathways with KEGG IDs, and mutatio...
Figure S3. DNA copy number alterations in the IBC cohort. The genes with DNA copy number alterations...
Supplementary Tables. Table S1 lists the number of SNV and indel mutations found in each individual ...
Figure S2. Comparison of biological pathway between IBC and non-IBC in four subgroups. (a) The perce...